Colorado Therapeutics LLC — Form D
Colorado Therapeutics LLC of BROOMFIELD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-17. The offering totals $15.0M, of which $2.6M was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-04-17
- Form: D
- Accession: 0001672459-17-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $2.6M
- Remaining: $12.4M
- Minimum investment: $100K
- Investors: 5
- Date of first sale: 2017-04-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-284943
Issuer
- Name: Colorado Therapeutics LLC
- CIK: 0001672459
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2150 WEST 6TH AVENUE, BROOMFIELD, CO, 80020
- Phone: 303-469-9459
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| James Gleason | Director | Huntsville, AL |
| Joseph Horn | Director | Broomfield, CO |
| Thomas Reagan | Director | Broomfield, CO |
| Joseph Horn | Executive Officer | Broomfield, CO |
| William Jackson | Executive Officer | Atlanta, GA |
| Eric Schauble | Executive Officer | Broomfield, CO |
| James Gleeson | Director | Broomfield, CO |
| Thomas Raegan | Director | Broomfield, CO |
| Eric Schabule | Executive Officer | Broomfield, CO |
Other filings by this issuer (1)
More